Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Nuclear medicine imaging in neuroblastoma: current status and new developments
Neuroblastoma is the most common extracranial solid malignancy in children. At diagnosis,
approximately 50% of patients present with metastatic disease. These patients are at high …
approximately 50% of patients present with metastatic disease. These patients are at high …
Current status and future perspective on molecular imaging and treatment of neuroblastoma
L Feng, S Li, C Wang, J Yang - Seminars in Nuclear Medicine, 2023 - Elsevier
Neuroblastoma is the most common extracranial solid tumor in children and arises from
anywhere along the sympathetic nervous system. It is a highly heterogeneous disease with …
anywhere along the sympathetic nervous system. It is a highly heterogeneous disease with …
[18F]mFBG PET-CT for detection and localisation of neuroblastoma: a prospective pilot study
Abstract Purpose Meta-[18F] fluorobenzylguanidine ([18F] mFBG) is a positron emission
tomography (PET) radiotracer that allows for fast and high-resolution imaging of tumours …
tomography (PET) radiotracer that allows for fast and high-resolution imaging of tumours …
The evidence-based role of catecholaminergic PET tracers in neuroblastoma. A systematic review and a head-to-head comparison with mIBG scintigraphy
Background Molecular imaging is pivotal in staging and response assessment of children
with neuroblastoma (NB).[123I]-metaiodobenzylguanidine (mIBG) is the standard imaging …
with neuroblastoma (NB).[123I]-metaiodobenzylguanidine (mIBG) is the standard imaging …
Heterogeneity of bone metastases as an important prognostic factor in patients affected by oestrogen receptor-positive breast cancer. The role of combined [18F] …
Purpose To assess the prognostic role of different inter and intralesional expression
(heterogeneity) of oestrogen receptor (ER) in bone metastases, as identified by the …
(heterogeneity) of oestrogen receptor (ER) in bone metastases, as identified by the …
The cutting edge: Promising oncology radiotracers in clinical development
Molecular imaging moves forward with the development of new imaging agents, and among
these are new radiotracers for nuclear medicine applications, particularly positron emission …
these are new radiotracers for nuclear medicine applications, particularly positron emission …
Prognostic value of interim 18F-DOPA and 18F-FDG PET/CT findings in stage 3–4 pediatric neuroblastoma
KY Ko, RF Yen, CL Ko, SW Chou… - Clinical Nuclear …, 2022 - journals.lww.com
Purpose This retrospective study aimed to determine the prognostic value of imaging
parameters derived from midtherapy 18 F-fluorodihydroxyphenylalanine (18 F-DOPA) and …
parameters derived from midtherapy 18 F-fluorodihydroxyphenylalanine (18 F-DOPA) and …
Role of dynamic parameters of 18F-DOPA PET/CT in pediatric gliomas
Results Fifteen patients were included; T/S, T/N, TTP, TAC slope steepness, and DSR were
not significantly different between HG and LG. The accumulation TAC shape was more …
not significantly different between HG and LG. The accumulation TAC shape was more …
The impact of PET/CT on paediatric oncology
This review paper will discuss the use of positron emission tomography/computed
tomography (PET/CT) in paediatric oncology. Functional imaging with PET/CT has proven …
tomography (PET/CT) in paediatric oncology. Functional imaging with PET/CT has proven …
Imaging of pediatric neuroblastoma: a COG diagnostic imaging committee/SPR oncology committee white paper
HA Lai, SE Sharp, A Bhatia, KR Dietz… - Pediatric blood & …, 2022 - pmc.ncbi.nlm.nih.gov
Imaging of Pediatric Neuroblastoma: A COG Diagnostic Imaging Committee/SPR Oncology
Committee White Paper - PMC Skip to main content Here's how you know Official websites use …
Committee White Paper - PMC Skip to main content Here's how you know Official websites use …